Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year. The drug is significant because it is the first non-steroidal therapy ...

While the cream did stop her itching, Natalie’s eczema persisted ... non-steroid topicals like tacrolimus and eucrisa, oral ...